-
1
-
-
32944456408
-
3 nanoparticles combined with magnetic fluid hyperthermia on cultured liver cancer cells and xenograft liver cancers
-
Yan, S.Y.; Zhang, D.S.; Gu, N.; Zheng, J.; Ding, A.; Wang, Z.; Xing, B.; Ma, M.; Zhang, Y. Therapeutic effect of Fe2O3 nanoparticles combined with magnetic fluid hyperthermia on cultured liver cancer cells and xenograft liver cancers. J. Nanosci. Nanotechnol. 2005, 5, 1-8.
-
(2005)
J. Nanosci. Nanotechnol
, vol.5
, pp. 1-8
-
-
Yan, S.Y.1
Zhang, D.S.2
Gu, N.3
Zheng, J.4
Ding, A.5
Wang, Z.6
Xing, B.7
Ma, M.8
Zhang, Y.9
-
2
-
-
33644855144
-
Arsenic trioxide synergizes with B7H3-mediated immunotherapy to eradicate hepatocellular carcinomas
-
Luo, L.Q.; Qiao, H.Q.; Meng, F.Q. Arsenic trioxide synergizes with B7H3-mediated immunotherapy to eradicate hepatocellular carcinomas. Int. J. Cancer 2006, 118, 1823-1830.
-
(2006)
Int. J. Cancer
, vol.118
, pp. 1823-1830
-
-
Luo, L.Q.1
Qiao, H.Q.2
Meng, F.Q.3
-
3
-
-
0035863397
-
Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of P53 and activation of caspase-3
-
Jiang, X.H.; Wong, B.C.; Yuen, S.T.; Jiang, S.H.; Cho, C.H.; Lai, K.C.; Lin, M.C.; Kung, H.F.; Lam, S.K. Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of P53 and activation of caspase-3. Int. J. Cancer 2002, 91, 173-179.
-
(2002)
Int. J. Cancer
, vol.91
, pp. 173-179
-
-
Jiang, X.H.1
Wong, B.C.2
Yuen, S.T.3
Jiang, S.H.4
Cho, C.H.5
Lai, K.C.6
Lin, M.C.7
Kung, H.F.8
Lam, S.K.9
-
4
-
-
16644398131
-
3) on human breast cancer cells
-
Chow, S.K.; Chan, J.Y.; Fung, K.P. Inhibition of cell proliferation and the action mechanisms of Arsenic Trioxide (As2O3) on human breast cancer cells. J. Cell. Biochem. 2004, 93, 173-187.
-
(2004)
J. Cell. Biochem
, vol.93
, pp. 173-187
-
-
Chow, S.K.1
Chan, J.Y.2
Fung, K.P.3
-
5
-
-
78650349884
-
3's application from the past to now
-
Hua, Q.H.; Wang, J.H.; Qin, K.S. Discussion of As2O3's application from the past to now. Chin. J. Chin. Mat. Med. 2003, 28, 186-189.
-
(2003)
Chin. J. Chin. Mat. Med
, vol.28
, pp. 186-189
-
-
Hua, Q.H.1
Wang, J.H.2
Qin, K.S.3
-
6
-
-
42149194383
-
Arsenic trioxide-induced apoptosis in h9c2 cardiomyocytes: Implications in cardiotoxicity. Basic Clin
-
Zhao, X.Y.; Feng, T.M.; Chen, H.; Shan, H.L.; Zhang, Y.; Lu, Y.J.; Yang, B.F. Arsenic trioxide-induced apoptosis in h9c2 cardiomyocytes: implications in cardiotoxicity. Basic Clin. Pharmacol. Toxicol. 2008, 102, 419-425.
-
(2008)
Pharmacol. Toxicol.
, vol.102
, pp. 419-425
-
-
Zhao, X.Y.1
Feng, T.M.2
Chen, H.3
Shan, H.L.4
Zhang, Y.5
Lu, Y.J.6
Yang, B.F.7
-
8
-
-
0037036157
-
Effect of arsenic trioxide on human hepatocellular carcinoma HepG2 cells: Inhibition of proliferation and induction of apoptosis
-
Siu, K.P.; Fung, K.P. Effect of arsenic trioxide on human hepatocellular carcinoma HepG2 cells: Inhibition of proliferation and induction of apoptosis. Life Sci. 2002, 71, 275-278.
-
(2002)
Life Sci.
, vol.71
, pp. 275-278
-
-
Siu, K.P.1
Fung, K.P.2
-
9
-
-
70350028879
-
Effects of ferromagnetic fluid hyperthermia induced by an alternative magnetic field on hepatoma cell HepG2 in vitro
-
He, L.X.; Zhang, Y.D.; He, J.T.; Li, N.F. Effects of ferromagnetic fluid hyperthermia induced by an alternative magnetic field on hepatoma cell HepG2 in vitro. Chin. J. Mod. Med. 2007, 17, 1041-1045.
-
(2007)
Chin. J. Mod. Med
, vol.17
, pp. 1041-1045
-
-
He, L.X.1
Zhang, Y.D.2
He, J.T.3
Li, N.F.4
-
10
-
-
34347228643
-
Preparation and characterization of nano-magnetoparticles with radiofrequency-induced hyperthermia for cancer treatment
-
Fan, X.S.; Zhang, D.S.; Zheng, J.; Gu, N.; Ding, A.W.; Jia, X.P.; Qin, H.Y.; Jin, L.Q.; Wan, M.L.; Li, Q.H. Preparation and characterization of nano-magnetoparticles with radiofrequency-induced hyperthermia for cancer treatment. J. Biomed. Eng. 2006, 23, 809-813.
-
(2006)
J. Biomed. Eng
, vol.23
, pp. 809-813
-
-
Fan, X.S.1
Zhang, D.S.2
Zheng, J.3
Gu, N.4
Ding, A.W.5
Jia, X.P.6
Qin, H.Y.7
Jin, L.Q.8
Wan, M.L.9
Li, Q.H.10
-
11
-
-
84876626581
-
3 in the treatment of advanced primary liver cancer
-
Fuzhou, Fujian, China, October, 17
-
Qian, J.; Qin, S.K.; He, Z.M.; Wang, L. Chen Y.X.; Shao, Z.J. Study on As2O3 in the treatment of advanced primary liver cancer. The 7th National Conference on Cancer Pharmacology and Chemotherapy, Fuzhou, Fujian, China, October, 17, 2001.
-
(2001)
The 7th National Conference on Cancer Pharmacology and Chemotherapy
-
-
Qian, J.1
Qin, S.K.2
He, Z.M.3
Wang, L.4
Chen, Y.X.5
Shao, Z.J.6
-
12
-
-
0032933610
-
Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system
-
Dai, J.; Weinberg, S.R.; Waxman, S.; Jing, Y. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 1999, 93, 268-277.
-
(1999)
Blood
, vol.93
, pp. 268-277
-
-
Dai, J.1
Weinberg, S.R.2
Waxman, S.3
Jing, Y.4
-
13
-
-
0031657760
-
Involvement of reactive oxygen species and caspase 3 activation in arsenic-induced apoptosis
-
Chen, Y.C.; Lin-shiau, S.Y.; Lin, J.K. Involvement of reactive oxygen species and caspase 3 activation in arsenic-induced apoptosis. J. Cell. Physiol. 1998, 177, 324-333.
-
(1998)
J. Cell. Physiol
, vol.177
, pp. 324-333
-
-
Chen, Y.C.1
Lin-Shiau, S.Y.2
Lin, J.K.3
-
14
-
-
0034212785
-
Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis
-
Park, W.H.; Seol, J.G.; Kim, E.S.; Hyun, J.M.; Jung, C.W.; Lee, C.C.; Kim, B.K.; Lee, Y.Y. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res. 2000, 60, 3065-3071.
-
(2000)
Cancer Res
, vol.60
, pp. 3065-3071
-
-
Park, W.H.1
Seol, J.G.2
Kim, E.S.3
Hyun, J.M.4
Jung, C.W.5
Lee, C.C.6
Kim, B.K.7
Lee, Y.Y.8
-
15
-
-
0033526358
-
Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations
-
Zhu, X.H.; Shen, Y.L.; Jing, Y.K.; Cai, X.; Jia, P.M.; Huang, Y.; Tang, W.; Shi, G.Y.; Sun, Y.P.; Dai, J.; Wang, Z.Y.; Chen, S.J.; Zhang, T.D.; Waxman, S.; Chen, Z.; Chen, G.Q. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J. Natl. Cancer Inst. 1999, 91, 772-778.
-
(1999)
J. Natl. Cancer Inst
, vol.91
, pp. 772-778
-
-
Zhu, X.H.1
Shen, Y.L.2
Jing, Y.K.3
Cai, X.4
Jia, P.M.5
Huang, Y.6
Tang, W.7
Shi, G.Y.8
Sun, Y.P.9
Dai, J.10
Wang, Z.Y.11
Chen, S.J.12
Zhang, T.D.13
Waxman, S.14
Chen, Z.15
Chen, G.Q.16
-
16
-
-
28644435153
-
Study on relationship between expressions of CD44 and inhibition effect of arsenic trioxide on carcinoma
-
Liu, T.F.; Cheng, B.L.; Guan, Y.G.; Liang, T. Study on relationship between expressions of CD44 and inhibition effect of arsenic trioxide on carcinoma. J. Harbdi. Med. 2000, 35, 111-112.
-
(2000)
J. Harbdi. Med
, vol.35
, pp. 111-112
-
-
Liu, T.F.1
Cheng, B.L.2
Guan, Y.G.3
Liang, T.4
-
17
-
-
0033572313
-
Arsenic trioxide causes selective necrosis in solid murine tumors by vascular shutdown
-
Lew, Y.S.; Brown, S.L.; Griffin, R.J.; Song, C.W.; Kim, J.H. Arsenic trioxide causes selective necrosis in solid murine tumors by vascular shutdown. Cancer Res. 1999, 59, 6033-6037.
-
(1999)
Cancer Res
, vol.59
, pp. 6033-6037
-
-
Lew, Y.S.1
Brown, S.L.2
Griffin, R.J.3
Song, C.W.4
Kim, J.H.5
-
18
-
-
0036547344
-
Arsenic trioxide: Mechanisms of action
-
Davison, K.; Mann, K.K.; Miller, W.H. Arsenic trioxide: mechanisms of action. Semin. Hematol. 2002, 39, 3-7.
-
(2002)
Semin. Hematol.
, vol.39
, pp. 3-7
-
-
Davison, K.1
Mann, K.K.2
Miller, W.H.3
-
19
-
-
33644855144
-
Arsenic trioxide synergizes with B7H3-mediated immunotherapy to eradicate hepatocellular carcinomas
-
Luo, L.Q.; Qiao, H.Q.; Meng, F.Q.; Dong, X.S.; Zhou, B.G.; Jiang, H.C.; Kanwar, J.R.; Krissansen, G.W.; Sun, X.Y. Arsenic trioxide synergizes with B7H3-mediated immunotherapy to eradicate hepatocellular carcinomas. Int. J. Cancer 2006, 118, 1823-1830.
-
(2006)
Int. J. Cancer
, vol.11
, pp. 1823-1830
-
-
Luo, L.Q.1
Qiao, H.Q.2
Meng, F.Q.3
Dong, X.S.4
Zhou, B.G.5
Jiang, H.C.6
Kanwar, J.R.7
Krissansen, G.W.8
Sun, X.Y.9
|